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Key points
 Spinal parvalbumin-expressing interneurons have been identified as a critical source of
inhibition to regulate sensory thresholds by gating mechanical inputs in the dorsal horn.
 This study assessed the inhibitory regulation of the parvalbumin-expressing interneurons,
showing that synaptic and tonic glycinergic currents dominate, blocking neuronal or glial
glycine transporters enhances tonic glycinergic currents, and these manipulations reduce
excitability.
 Synaptically released glycine also enhanced tonic glycinergic currents and resulted in decreased
parvalbumin-expressing interneuron excitability.
 Analysis of the glycine receptor properties mediating inhibition of parvalbumin neurons, as
well as single channel recordings, indicates that heteromeric α/β subunit-containing receptors
underlie both synaptic and tonic glycinergic currents.
 Our findings indicate that glycinergic inhibition provides critical control of excitability in
parvalbumin-expressing interneurons in the dorsal horn and represents a pharmacological
target to manipulate spinal sensory processing.
Abstract The dorsal horn (DH) of the spinal cord is an important site for modality-specific
processing of sensory information and is essential for contextually relevant sensory experience.
Parvalbumin-expressing inhibitory interneurons (PV+ INs) have functional properties and
connectivity that enables them to segregate tactile and nociceptive information. Here we examine
inhibitory drive to PV+ INs using targeted patch-clamp recording in spinal cord slices from adult
transgenicmice that express enhancedgreenfluorescentprotein inPV+ INs.Analysis of inhibitory
synaptic currents showed glycinergic transmission is the dominant form of phasic inhibition to
PV+ INs. In addition, PV+ INs expressed robust glycine-mediated tonic currents; however,
we found no evidence for tonic GABAergic currents. Manipulation of extracellular glycine by
blocking either, or both, the glial and neuronal glycine transporters markedly decreased PV+ IN
excitability, as assessed by action potential discharge. This decreased excitability was replicated
when tonic glycinergic currents were increased by electrically activating glycinergic synapses.
Finally, we show that both phasic and tonic forms of glycinergic inhibition are mediated by
heteromeric α/β glycine receptors. This differs from GABAA receptors in the dorsal horn, where
different receptor stoichiometries underlie phasic and tonic inhibition.Together these data suggest
both phasic and tonic glycinergic inhibition regulate the output of PV+ INs and contribute to
the processing and segregation of tactile and nociceptive information. The shared stoichiometry
for phasic and tonic glycine receptors suggests pharmacology is unlikely to be able to selectively
target each form of inhibition in PV+ INs.
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Introduction
The dorsal horn (DH) of the spinal cord contains
a heterogeneous population of neurons that process
information related to nociceptive, light touch, itch
and thermal modalities (Todd, 2010). Integration or
segregation of these modalities is considered critical for
normal sensory experience, and inappropriate mixing of
sensory signals in the DH is thought to cause aberrant
sensations such as allodynia, hyperalgesia, spontaneous
pain and itch. A large literature, beginning with the gate
control theory of pain (Melzack & Wall, 1965), assigns
a crucial role for synaptic inhibition in maintaining
contextually relevant sensory processing, employing both
in vivo (Yaksh, 1989; Ishikawa et al. 2000) and in
vitro preparations (Ruscheweyh & Sandkuhler, 2005;
Takazawa & MacDermott, 2010). More recently, a series
of sophisticated studies employing neuron-specific trans-
plantation (Braz et al. 2012), paired recordings (Lu &
Perl, 2003), and targeted ablation, silencing and activation
(Duan et al. 2014; Bourane et al. 2015; Foster et al. 2015;
Petitjean et al. 2015; Cui et al. 2016) have confirmed the
importance of inhibition for normal sensory processing
and in the development of certain pain states.
We have characterized a specific population of inter-
neurons that express the calcium binding protein
parvalbumin (PV+) (Hughes et al. 2012) and are broadly
considered inhibitory, although a small population of
excitatory PV+ INs has also been reported (Antal et al.
1991). Despite this, our work in the PV-green fluorescent
protein (GFP) transgenicmouse showed thatGFP-labelled
PV+ INs had electrophysiological, morphological and
neurochemical properties consistent with an inhibitory
phenotype; and that PV-GFP axon varicosities were
vesicular GABA transporter (VGAT) positive. This work
also showed that PV+ INs receive monosynaptic input
from myelinated afferents, and provide a source of
axo-axonic input onto the central terminals of these
afferents (Hughes et al. 2012). Such connectivity implies
a feed-forward inhibitory circuit could exist to selectively
regulate the effect of innocuous tactile input during spinal
sensory processing. It follows that a reduction in the
inhibition mediated by these neurons could contribute
to development of tactile allodynia. Subsequent work has
verified these predictions by showing that genetic ablation
of PV+ INs in the DH reduces sensory thresholds as
observed in allodynia (Petitjean et al. 2015). Furthermore,
this work showed that increased activation of PV+ INs in
neuropathic mice restored normal sensory thresholds and
attenuated allodynia.
Given this role forPV+ INs inmodality-specific sensory
processing, the manner in which their activation or
excitability is regulated will be important for developing
strategies to alter the activity of this population. For
example, we have shown that PV+ INs can support high
frequency action potential (AP) discharge and express the
hyperpolarization-activated cation current (Ih), which is
associated with repetitive AP firing (Hughes et al. 2012).
Together, these properties make PV+ INs a powerful
source of inhibition in the DH. Paradoxically, we also
showed that PV+ INs have a relatively high rheobase
current and receive weak synaptic excitation, which imply
they may be difficult to recruit.
In order to determine how PV+ INs are recruited
during spinal sensory processing it is important to also
fully characterize the inhibition they receive. It is well
established that both GABA and glycine mediate fast
synaptic inhibition in the DH (Chery & de Koninck,
1999; Graham et al. 2003; Baccei & Fitzgerald, 2004;
Anderson et al. 2009; Takazawa&MacDermott, 2010) and
that populations of DH neurons can receive inhibition
dominated by GABA, glycine, or both. It has also been
shown that a dorsoventral gradient exists in the inhibitory
transmitter phenotype within the DH. GABA is more
dominant in superficial layers, whereas glycine dominates
in the deep DH and ventral horn (Cronin et al. 2004;
Anderson et al. 2009). In addition to their role in fast
synaptic inhibition, both GABA and glycine are known
to mediate tonic inhibitory currents that are capable
of suppressing AP discharge (Takazawa & MacDermott,
2010). Therefore, in this study we assess the levels of
synaptic and tonic inhibition mediated by GABA and
glycine onto PV+ INs, determine their respective roles
in regulating AP discharge, and explore the stoichiometry
of synaptic and extrasynaptic receptor populations. This
informationprovides new insights onhowalteringGABA-
orglycinergic transmissioncanaffect spinal inhibition that
ismediated by PV+ INs and how thesemechanismsmight
be targeted pharmacologically.
Methods
All experiments were approved by the University of
Newcastle (UoN) Animal Care and Ethics Committee.
We used a transgenic mouse line (both sexes; aged
29 ± 3 weeks; body weight 17–27 g) that expressed
enhanced green fluorescent protein (eGFP) under the
control of the parvalbumin promoter (PVeGFP: Meyer
et al. 2002). The line was originally generated by Professor
Hana Monyer and bred on the BalbC background with
permission atUoN.UV illuminationof the ears of PVeGFP
mice was used to identify eGFP-positive animals: fast
twitch muscle fibres also express parvalbumin (and by
association eGFP).
Acute spinal slice preparation
Spinal cord sliceswerepreparedusingpreviouslydescribed
techniques (Graham et al. 2003; Smith et al. 2015). Briefly,
animals (PVeGFP) were anaesthetized with ketamine
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
J Physiol 595.23 Phasic and tonic glycinergic inhibition in the spinal dorsal horn 7187
(100 mg kg−1 I.P.) and decapitated. Using a ventral
approach, the lumbosacral enlargement of the spinal
cord was rapidly removed and placed in ice-cold
sucrose-substituted artificial cerebrospinal fluid (ACSF)
containing (in mM): 250 sucrose, 25 NaHCO2, 10 glucose,
2.5 KCl, 1 NaH2PO4, 1 MgCl2 and 2.5 CaCl2. Trans-
verse or parasagittal slices (from L3–L5 segments cut at
300 and 200 μm thickness, respectively) were obtained
using a vibratingmicrotome (LeicaVT-1000S,Heidelberg,
Germany). Slices were then transferred to an inter-
face incubation chamber containing oxygenated ACSF
(118 mM NaCl substituted for sucrose) and allowed to
equilibrate for 1 h (at 22–24°C) prior to recording.
Electrophysiology
Slices were transferred to a recording chamber and
continually superperfused (bath volume 0.4 ml; exchange
rate 4–6 bath volumes min−1) with ACSF bubbled with
Carbonox (95% O2 and 5% CO2) to achieve a final pH
of 7.3–7.4. Neurons were visualized using near-infrared
differential interference contrast optics. PV+ INs were
identified under fluorescence using a fluorescein iso-
thiocyanate (FITC) filter set (488 nm excitation and
508 nm emission filters) (Hughes et al. 2012). Neuro-
biotin (0.2%) was included in internal solutions for
post hoc confirmation of GFP expression in a subset of
recordings (Vector Laboratories, Peterborough, UK). As
previously reported, the majority of PVeGFP-expressing
cells are immunopositive for parvalbumin (Hughes et al.
2012). Recordings were limited to neurons located within
or close to the substantia gelatinosa. This area is easily
identified by its translucent appearance in transverse
and parasagittal spinal cord slices and contains a clearly
discernable plexus of PV+ INs. All recordings were
obtained at room temperature (21–24°C). Patch pipettes
(4–8 M) were filled with one of two internal solutions.
A caesium chloride-based internal was used for recording
inhibitory currents. This internal contained (in mM): 130
CsCl, 10 Hepes, 10 EGTA, 1 MgCl2, 2 ATP and 0.3 GTP
(pH adjusted to 7.35 with 1 M CsOH). A potassium
gluconate-based internal solutionwas used in experiments
where the action potential discharge was examined and
analysed. This internal contained (in mM): 135 KCH3SO4,
6 NaCl, 2 MgCl2, 10 Hepes, 0.1 EGTA, 2 MgATP, 0.3
NaGTP (pH adjusted to 7.3 with KOH).
All whole-cell recordings were first established in
voltage clamp (holding potential −70 mV). Data were
acquired using a Multiclamp 700B amplifier (Molecular
Devices, Sunnyvale, CA, USA), digitized online (sampled
at 10–20 kHz and filtered at 5–10 kHz) via an ITC-18
computer interface (Instrutech, Long Island, NY, USA)
and stored on a Macintosh computer using Axograph
X software (Kagi, Berkley, CA, USA). After obtaining
the whole-cell recording configuration, series resistance,
neuron input resistance and membrane capacitance were
calculatedbasedon the response to a5mVhyperpolarizing
voltage step (10 ms duration) from a holding potential of
−70 mV. These values were monitored at the beginning
and end of each recording session and data were rejected
if values changed by more than 30%.
Miniature inhibitory postsynaptic currents (mIPSCs),
which represent the postsynaptic response to spontaneous
release of single vesicles of neurotransmitter (Katz &
Miledi, 1969; Bekkers & Stevens, 1989; Callister &
Walmsley, 1996), were pharmacologically isolated by
including the sodium channel blocker tetrodotoxin
(TTX; 1 μM) and the AMPA/kainate receptor antagonist
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 10 μM)
in the bath perfusate. The currents recorded under
these conditions in the mouse DH are mediated by
the action of GABA, glycine, or both. In order to iso-
late glycinergic currents the GABAA receptor antagonist
bicuculline (10 μM) was next added to the bath. In
a subset of experiments NMDA receptor antagonist
DL-2-amino-5-phosphonovaleric acid (APV; 50 μM) was
then bath applied to exclude NMDA receptor activation,
but this had no effect. All remaining currents were
abolished by bath application of strychnine (1 μM). At
least 3 min of data were acquired under both conditions
(pre- and post-bicuculline application) for analysis. In
some experiments picrotoxin (10 μM) and/or lindane
(30 μM) was applied to test for the presence of homo-
meric glycine receptors. Similarly, selective glycine trans-
porter blockersOrg 25543 (10μM) andOrg 24598 (10μM)
were bath-applied to assess the role of the neuronal and
glial transporters (GlyT2 and GlyT1, respectively) in tonic
current characteristics. Outside-out membrane patches
(Hamill et al. 1981) were excised at the conclusion of
some PV+ IN recordings and exposed to bath application
of 2.5–10 μM glycine to evoke single channel glycine
receptor-mediated currents. Single channel events were
filtered at 1 kHz.
A separate series of experiments assessed PV+ IN AP
discharge in current-clamp mode using the potassium
gluconate-based internal solution, and bridge balance
monitored throughout recordings. Neuronal excitability
and AP discharge were studied by injecting a series
of depolarizing step currents (800 ms duration, 20 pA
increments, delivered every 8 s) into the recorded neuron
when it was held at a membrane potential of −60 mV.
During this protocol voltage deflections were limited,
to avoid cell damage, by terminating the protocol if
sustained depolarizations exceeded −20 mV (i.e. in parts
of the voltage trace not containing APs). After this initial
characterization of excitability glycinergic signalling was
modified by either blocking glycine receptors (GlyRs) or
GlyT1/GlyT2 transporters with strychnine or Org 24598
andOrg25543, respectively. Excitabilitywas assessedwhen
either GlyRs or the transporter were blocked.
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To assess the role of endogenous glycine, electrically
evoked IPSCs (eIPSCs) were elicited using a bipolar glass
stimulating electrode (20 μm tip separation) positioned
200–800 μm rostral or caudal to the recorded PV+
IN. A number of stimulation protocols were applied
including a single 1 ms duration stimulus, 10 stimuli
at 10 Hz, 10 stimuli at 20 Hz and 20 stimuli at 20 Hz
via a transistor-transistor logic (TTL)-driven ISO-Flex
stimulator (A.M.P.I., Jerusalem, Israel). A protocol that
delivered three successive trials of depolarizing step
currents (800 ms duration, 20 pA increments, delivered
every 10 s) to the recorded PV+ IN was used to assess
the effect of stimulation-evoked endogenous glycine on
AP discharge. Tonic glycinergic currents were evoked
prior to the second depolarizing step trial (Fig. 4B) using
bipolar stimulation (20 stimuli, at 20 Hz). Importantly,
bipolar stimulation was maintained at 10% below
threshold for Na+ channel activation in all protocols
and recordings were made in the presence of CNQX and
bicuculline.
Data analysis
Analysis of mIPSCs was completed using a sliding
template method (semi-automated procedure within
Axograph software package) to detect and capturemIPSCs
(Clements & Bekkers, 1997). All captured mIPSCs were
inspected individually and excluded from further analysis
if they contained overlapping mIPSCs or had an unstable
baseline before the rise or during the decay phase of
the mIPSCs. Data were also rejected if a significant
trend in either mIPSC amplitude or inter-event inter-
val was observed during the analysis period. The peak
amplitude and rise time of mIPSCs were measured for
all accepted events (via semi-automated procedures in
Axograph) and instantaneous frequency was calculated
as the reciprocal of inter-event interval. Analysis of the
mIPSC decay time constant (calculated over 20–80% of
the decay phase) was performed on averaged mIPSCs,
generated by aligning the rising phase of all accepted
events in a recording. Tonic currents were analysed by
calculating the change in baseline holding current and
standard deviation (baseline noise) before and after bath
application of bicuculline, strychnine, APV, picrotoxin,
lindane,Org24598,Org25543, or both glycine transporter
blockers. Single channel events recorded in outside-out
membrane patches were captured from continuous
recordings using an amplitude threshold detection and
all-points histograms were then constructed to calculate
mean single channel current and conductance for each
membrane patch (n = 16).
In experiments that assessed the relationship between
evoked endogenous glycine release and tonic glycinergic
currents we measured baseline current and baseline
noise over a 10 ms epoch (30–40 ms after the stimulus
artefact). Measurements were made over this epoch to
avoid contamination by evoked synaptic currents. Data
were normalized to pre-stimulus current values. The time
for the evoked current to return tobaselinewas taken as the
time from the stimulus artefact until the current returned
to zero. In experiments involving drug application data
were normalized to control responses (no drug) and traces
zeroed to baseline.
AP discharge was classified according to previously
published criteria (Graham et al. 2004, 2007). In
agreement with our previous work, PV+ INs expressed
either tonic discharge, characterized by persistent AP
discharge throughout the depolarizing step, or initial
bursting discharge, characterized by AP discharge limited
to the beginning of the depolarizing step. The criterion
for inclusion of a neuron in this analysis was a resting
membrane potential more negative than –50 mV and
a series resistance <30 M (filtered at 5 kHz). In
our analysis of AP discharge, individual APs elicited by
step-current injection were captured using a derivative
threshold method (dV/dt  15 V s−1) with the inflection
point during spike initiation defined as AP threshold.
The difference between AP threshold and its maximum
positive peak was defined as AP amplitude. AP base width
wasmeasured at AP threshold. AP after-hyperpolarization
amplitude was taken as the difference between AP
threshold and the maximum negative peak following the
AP. Rheobase current was defined as the smallest step
current that would elicit at least one AP.
In recordings that assessed the impact of altered
glycinergic inhibition on PV+ IN discharge (i.e.
strychnine or glycine transporter blocker application),
the impact of neuron-to-neuron variability in rheobase
current was removed by normalization. This was
achieved by normalizing responses to rheobase and then
reporting subsequent responses in 20 pA increments
above rheobase. In addition, the number of APs elicited
and instantaneous frequency were normalized to values
obtained in the 40 pA current step response under control
conditions (i.e. no drug). Therefore, AP number and
instantaneous frequency at this 40 pA step are reported
as 100%. Drug-induced differences in AP number and
instantaneous frequency are reported as a percentage
of this value. Changes in AP discharge during end-
ogenously evoked glycine were assessed by normalizing
values obtained from the second and third depolarizing
step trials to data obtained from the first trial.
Single channel events recorded in outside-out
membrane patches were captured from continuous
recordings using amplitude threshold detection and all-
points histograms were then constructed. To calculate
mean single channel current and conductance, one or two
Gaussiandistributionswerefitted toall-pointshistograms.
All drugs were obtained from Sigma Aldrich (Sydney,
Australia) unless otherwise stated.
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Statistics
Statistical analysis was carried out using SPSS v10 (SPSS
Inc. Chicago, IL, USA). Student’s t tests were used to
compare variables between genotypes. Data that failed
Levene’s test for homogeneity of variance were compared
using the non-parametric Kruskal–Wallis test. Statistical
significance was set at P < 0.05. All values are presented
as means ± SEM.
Results
Glycinergic synaptic inhibition dominates in PV+ INs
To assess the relative contribution of GABA and glycine
to synaptic inhibition in PV+ INs we recorded ‘mixed’
mIPSCs in the presence of CNQX and TTX (n = 11), and
then assessed their bicuculline sensitivity (Fig. 1A). Any
currents remaining after the addition of bicuculline (i.e.
bicuculline insensitive) were considered glycinergic. This
was confirmed by bath application of the glycine receptor
antagonist strychnine, which abolished all remaining
activity. In most recordings from PV+ INs comparison
of mixed and glycinergic mIPSCs indicated that there
was little difference between these conditions (Fig. 1B).
Plots showing the change inmIPSC frequency, amplitude,
rise time and decay time constant reveal that mixed
and glycinergic mIPSC properties were relatively stable,
although mIPSC frequency was reduced in 3 of 11
recordings (Fig. 1C). Despite this, the mean value for
frequency (1.19 ± 0.26 Hz vs. 0.79 ± 0.17 Hz), amplitude
(109± 18 pA vs. 99± 17 pA), rise time (0.87± 0.07ms vs.
0.85 ± 0.09 ms), decay time constant (6.67 ± 0.77 ms
vs. 6.51 ± 0.48 ms) and goodness of fit of the decay
time constant (assessed using the sum of squares error:
0.67 ± 0.19 vs. 0.64 ± 0.14) were similar in mixed
and glycinergic mIPSCs. This analysis suggests glycinergic
transmission is the dominant form of inhibition to PV+
INs with GABAergic synaptic transmission playing a less
prominent role.
PV+ INs receive tonic glycinergic inhibition
A striking feature in the mIPSC recordings made after
the addition of strychnine was a clear shift in the holding
current and a reduction in baseline noise (Fig. 2A). This
is further emphasized in all-points histogram plots for the
two epochs: before and after strychnine addition. There
is a clear shift to the left (i.e. a reduction) in holding
current as well as a narrowing of the distribution following
the addition of strychnine. Together, these observations
indicate the presence of a tonic glycinergic current under
baseline conditions. Group data comparisons (n = 22)
show that strychnine significantly reduced the holding
current in our recordings by 50 pA (−99 ± 22 pA vs.
−49 ± 8 pA before and after strychnine, P = 0.012), and
the noise (standard deviation (SD)) of the baseline current
(9.90± 1.59 pA vs. 3.40± 0.46 pA, P< 0.001). In contrast,
therewas no evidence for the existence of tonicGABAergic
currents in PV+ INs after bath application of bicuculline
(n= 11) (Fig. 2B). Group comparisons of holding current
(−118 ± 33 pA vs. −120 ± 36 pA, P = 0.606), and base-
line current noise (9.70 ± 1.75 pA vs. 9.35 ± 1.96 pA,
P= 0.46) showed no change after bicuculline application.
To exclude a possible contribution of NMDA receptors to
tonic currents a subset of experiments assessed the effect
of APVbath application (n= 6; 2mice). In no instance did
APV cause a reduction in holding current (−104 ± 9 pA
vs. −111 ± 11 pA, P = 0.072), or baseline current
noise (6.88 ± 1.21 pA vs. 6.44 ± 1.04 pA, P = 0.254).
In contrast, strychnine significantly decreased holding
current (−104 ± 9 pA vs. −94 ± 10 pA, P = 0.011) and
baseline current noise (6.88 ± 1.21 pA vs. 2.31 ± 0.27 pA,
P = 0.009) consistent with our earlier recordings. Thus,
PV+ INs in theDHexpress robust tonic currentsmediated
by glycine, but we find no evidence for the existence of
tonic GABAergic or glutamatergic currents.
Glycine transporter blockade enhances tonic currents
To further assess the impact of altered extracellular glycine
levels on tonic inhibition of PV+ INs we undertook
a series of experiments that blocked the glial (GlyT1,
n = 11; 6 mice) and neuronal (GlyT2, n = 10; 5
mice) glycine transporters. Bath addition of the GlyT1
blockerOrg 24598 increased the holding current and base-
line noise. Conversely, holding current and noise were
reduced dramatically by bath application of strychnine
(Fig. 3A). These observations are further quantified
in the all-points histogram, which shows a rightward
shift and broadening of the current distribution after
addition of Org 24598. These effects were abolished
after the application of strychnine. Note, the reduced
amplitude of the tonic glycine currents observed here,
compared to those observed in Fig. 2A, emphasizes cell
to cell variability in tonic glycine current amplitude
and the potential for rundown associated with the
longer recordings necessitated by these experiments. Bath
addition of the GlyT2 blocker Org 25543 produced
virtually identical results to GlyT1 blockade. It enhanced
the tonic current and caused a rightward shift and
broadening in the all-points histogram (Fig. 3B). These
effects were completely reversed by bath application of
strychnine. Group data comparisons show that block
of both glial (GlyT1) and neuronal (GlyT2) transport
blockers increased the holding current by approximately
double (61 ± 5 pA vs. 106 ± 15 pA GlyT1, P = 0.003;
54 ± 5 pA vs. 116 ± 18 pA GlyT2, P = 0.004) as well
as the associated baseline noise (SD) (5.40 ± 0.81 pA vs.
9.80 ± 1.10 pA GlyT1, P = 0.001; 5.56 ± 0.71 pA vs.
10.34 ± 1.39 pA GlyT2, P = 0.015). Thus, both glial and
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
7190 M. A. Gradwell and others J Physiol 595.23
neuronal regulation of extrasynaptic glycine levels appear
to play an important role in mediating tonic currents in
PV+ INs. In a subset of experiments (n = 8; 4 mice)
both transporters were blocked (i.e. GlyT1 and GlyT2)
and, irrespective of the order of blockade, addition of the
second transporter blocker caused a further increase in
both holding current (67 ± 8 pA vs. 324 ± 44 pA, GlyT1
thenGlyT2, P= 0.001) and baseline noise (6.57± 0.91 pA
vs.19.06 ± 1.22 pA. GlyT1 then GlyT2, P = 0.001)
(Fig. 3C). This effect was greater than the summed
effect of each transporter alone, suggesting that under
conditions where only one transporter is blocked some
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Figure 1. Synaptic inhibition in PV+ INs
A, trace showing continuous mIPSC recording from a PV+ IN. Mixed mIPSCs were recorded in the presence of
CNQX (10 μM) and TTX (1 μM). Glycinergic mIPSCs are revealed following bath addition of the GABAA receptor
antagonist bicuculline (10 μM). Bath addition of the glycine receptor antagonist strychnine (1 μM) abolished
glycinergic mIPSCs. Inset, neurons were identified in infrared-differential interference contrast (IR-DIC) (top left),
and fluorescence (top right) was subsequently used to confirm the presence of GFP. In some recordings post hoc
recovery confirmed neurobiotin-filled cells (bottom left) were GFP+ (bottom right). B, left traces show overlaid
mixed and glycinergic mIPSCs captured from the recording epochs outlined by the light and dark grey rectangles
in A. Right traces show averaged decay waveforms for mixed and glycinergic mIPSCs. Red line shows fit for decay
time constant calculation. They were virtually identical for mixed and glycinergic mIPSCs. C, plots comparing mean
mIPSC properties (frequency, amplitude, rise time and decay time constant) in PV+ INs under recording conditions
that reveal mixed and glycinergic mIPSCs. The majority of recordings showed little change between conditions;
however, four recordings showed a reduction in mIPSC frequency when glycinergic mIPSCs were isolated. Most
PV+ INs showed little change in mIPSC amplitude, rise time and decay time constant between conditions. [Colour
figure can be viewed at wileyonlinelibrary.com]
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Figure 2. PV+ INs exhibit tonic glycine, but not GABAergic
currents
A, trace shows a continuous glycinergic mIPSC recording (in the
presence of TTX, CNQX and bicuculline), before and after bath
addition of strychnine. Note that in addition to abolishing glycinergic
mIPSCs, strychnine causes a shift in holding current and a reduction
in baseline noise. These features are indicative of a tonic
glycine-mediated current. Insets (a and b) show expanded epochs
highlighting the difference in baseline noise before and after
strychnine exposure. An all-points histogram (bottom left) from the
above epochs quantify the shift in holding current and reduction in
baseline noise after strychnine exposure. Bar graphs (bottom right)
are group data showing a significant reduction in holding current
and baseline noise in PV+ INs. Data for each neuron used in mean
calculation for bar graphs are shown as filled circles. B, same analysis
as for A, except the continuous trace shows GABAergic mIPSCs (in
the presence of TTX, CNQX and strychnine) before and after bath
addition of bicuculline. Note, bicuculline abolishes all GABAergic
mIPSCs but does not alter the holding current or baseline noise. This
residual capacity remains in the other transporter system
to clear glycine from the extracellular space. Blockade of
both transporters then causes a rapid elevation in glycine
concentration, further enhancing tonic glycine currents
and the associated holding current and baseline noise.
Glycinergic inhibition regulates PV+ IN action
potential discharge
In order to test the functional consequences of the
dominant glycinergic inhibitory control of PV+ INs,
we assessed their intrinsic excitability before and after
manipulation of glycinergic input. PV+ IN discharge was
first assessed by recording the AP discharge evoked during
injection of a series of depolarizing current steps. Unlike
classical fast spiking discharge described for PV+ INs in
higher CNS regions (hippocampus, cortex) spinal DH
PV+ IN discharge could be classified as either tonic firing,
characterized by sustained discharge for the duration of
current injection; or initial bursting, where discharge was
limited to the beginning of current injection; consistent
with our previous report (Hughes et al. 2012). Under
control conditions, both the number of evoked APs and
mean instantaneous firing frequency (F) increased with
increasing levels of current injection (from 0 to 100 pA).
These data are combined and presented as F–I plots in
Fig. 4 with values normalized to the level of discharge
evoked by the 40 pA current step (above rheobase) under
control conditions. After this initial trial we either blocked
glycinergic inhibition by bath-applying strychnine (1μM),
or enhanced it by applying theGlyT1blocker and/orGlyT2
blocker. Action potential discharge was then reassessed
3 min after drug application from the same control
membrane potential.
In the strychnine experiments (n = 14; 6 mice) half
the recordings initially exhibited tonic firing and half
showed initial bursting discharge. Comparisons of control
and strychnine data showed a significant shift to the
left in the F–I curve indicating PV+ INs became more
excitable (Fig. 4A). AP discharge rate more than doubled
(216 ± 38%, when normalized to the 40 pA step,
P = 0.009). In contrast, mean instantaneous frequency
did not change (102 ± 6%, normalized to the 40 pA
step, P = 0.754). In some initial bursting neurons (5/7)
addition of strychnine changed or ‘converted’ PV+ IN
discharge to the tonic firing mode. Likewise, strychnine
altered the discharge of tonic firing neurons by increasing
the number ofAPs dischargedper step,without converting
suggests tonic GABA currents are absent in PV+ INs. Insets (a and b)
show no difference in baseline noise before or during bicuculline
exposure. An all-points histogram (bottom left) and the bar graphs
(bottom right) show that holding current and baseline noise in PV+
INs do not differ before or during bicuculline exposure.
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Figure 3. PV+ IN tonic glycine currents are enhanced by
glycine transporter block
A, trace shows a continuous glycinergic mIPSC recording (in the
presence of TTX, CNQX and bicuculline) during sequential addition
of the GlyT1 blocker Org 24598 (Org G) and strychnine to the bath.
Org 24598 enhanced the tonic glycine current, as shown by an
firing mode. These data suggest that under our recording
conditions initial bursting neurons are strongly influenced
by glycinergic inhibition, and its removal increases their
capacity to support sustained AP discharge. To further
explore the lack or small effect of glycinergic inhibition
on tonic firing neurons we increased extracellular glycine
concentration by bath-applying Org 24598 (n = 11;
3 mice) and Org 25543 (n = 11; 8 mice) either
independently or together (n = 9; 5 mice). In these
GlyT blocker experiments, this manipulation caused a
rightward shift in the F–I plots for both tonic firing
(n= 16) and initial bursting (n= 7) neurons (Fig. 4B–D).
Group data comparisons show that application of glycine
transport blockers decreased the number of action
potentials below baseline values (38 ± 9% GlyT1,
P = 0.000; 39 ± 14% GlyT2, P = 0.002; 0 ± 0%
GlyT1 + GlyT2, P = 0.001, normalized to values at
40 pA current step) and also the instantaneous frequency
(73± 14%GlyT1, P= 0.086; 65± 16%GlyT2, P= 0.049;
0 ± 0% GlyT1 + GlyT2, P = 0.001). In most cases the
tonic firing discharge pattern was converted to initial
bursting or single spiking (17/21) and the initial bursting
discharge pattern converted to single spiking or reluctant
firing (6/10) followingGlyTblock. Thus, glycine levels and
the resulting inhibition play an important role in shaping
‘firing mode’ in both tonic firing and initial bursting
PV+ INs.
increased holding current and baseline noise. Addition of strychnine
abolished the tonic glycinergic current. Insets (a, b and c) above the
continuous mIPSC trace highlight the enhanced baseline noise after
the addition of Org 24598 (b) and its reduction by strychnine (c). An
all-points histogram (bottom left) from epochs a, b and c quantifies
the holding current shift, and baseline noise alterations during
Org 24598 and strychnine exposure. Bar graphs (bottom right)
compare group data and show that Org 24598 and strychnine shift
both holding current and baseline noise in PV+ INs. B, trace shows a
continuous recording of glycinergic mIPSCs during sequential bath
application of the GlyT2 blocker Org 25543 and strychnine.
Org 25543 (Org N) clearly enhanced the tonic glycine current. Insets
(a, b and c) above the mIPSC trace show Org 25543 enhanced
baseline noise whereas strychnine reduced it. An all-points
histogram (bottom left) from a, b and c shows the shifts in holding
current and baseline noise during Org 25543 and strychnine
exposure. Bar graphs (bottom right) compare group data showing
Org 25543- and strychnine-related holding current and baseline
noise shifts in PV+ INs. C, trace shows a continuous glycinergic
mIPSC recording, with the sequential bath addition of the GlyT1
blocker Org 24598, GlyT2 blocker Org 25543, and then strychnine.
Co-exposure to Org 24598 and Org 25543 dramatically enhanced
the tonic glycine current. Insets (a, b and c) highlight the enhanced
baseline noise during Org 24598 + Org 25543 application, and the
strychnine-mediated reduction. An all-points histogram (bottom left)
from these epochs quantifies the holding current shift and baseline
noise alterations under Org 24598 + Org 25543 and strychnine
exposure. Bar graphs (bottom right) compare group data showing
Org 24598 + Org 25543- and strychnine-related holding current
and baseline noise shifts in PV+ INs.
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Figure 4. PV+ IN excitability is sensitive to levels of glycinergic inhibition
A–D, left traces show action potential (AP) discharge responses of PV+ INs during depolarizing current step
injections, before and after manipulation of glycinergic inhibition with strychnine or glycine transporter inhibitors.
Right plots show group data summarizing AP discharge and frequency per step above rheobase current, as well
as subthreshold current–voltage (I–V) relationships. A, strychnine antagonism of glycine receptors increased AP
discharge. This increase is evident in the relationship between AP number versus current step (left); however, AP
discharge frequency (middle) was not changed by strychnine. B, traces show AP discharge decreased after GlyT1
blocker Org 24598 exposure. This decrease is clear in the group data plots of AP discharge and frequency per step
above rheobase. C, traces show AP discharge decreased after GlyT2 blocker Org 25543 exposure. This decrease is
clear in group data plots of AP discharge and frequency per step above rheobase. D, traces show combined GlyT1
and GlyT2 block with Org 24598 and Org 25543 dramatically decreased AP discharge. This dramatic effect is clear
in group data plots of AP discharge and frequency per step above rheobase. Insets in I–V plots show example
responses to 40 pA depolarizing current steps under control conditions and in the presence of glycine receptor
antagonist or inhibitors. [Colour figure can be viewed at wileyonlinelibrary.com]
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In an attempt to explain the observed changes in
spike number and frequency when glycine levels are
manipulated we examined the properties of the APs
recorded at spike threshold. Comparisons of the pre-
and post-strychnine data showed rheobase current was
unchanged (105±14%,P=0.726),whereas applicationof
GlyT blockers increased rheobase current (136 ± 12% for
GlyT1,P= 0.012; 178± 32%GlyT2,P= 0.039; 328± 71%
GlyT1+GlyT2,P= 0.012). Strychnine application caused
an increase in AP height (119 ± 5%, P = 0.003), but
no change in AP half-width (104 ± 3%, P = 0.141), or
after-hyperpolarization peak (102 ± 9%, P = 0.835). For
the most part, application of GlyT blockers resulted in no
change to AP peak amplitude (89± 3%GlyT1, P= 0.010;
104 ± 4% GlyT2, P = 0.334; 97 ± 2% GlyT1 + GlyT2,
P = 0.191), a slight increase in AP half-width (115 ± 9%
GlyT1, P = 0.136; 105 ± 4% GlyT2, P = 0.281;
112 ± 3% GlyT1 + GlyT2, P = 0.004), and little change
in after-hyperpolarization peak amplitude (96 ± 10%
GlyT1, P = 0.662; 86 ± 8% GlyT2, P = 0.130; 76 ± 11%
GlyT1+GlyT2, P= 0.069). The clear increase in rheobase
current helps explain the observed changes in AP number
and frequency. Simply put, enhanced glycine receptor
activation reduces neuronal input resistance (74 ± 6%
GlyT1, P = 0.002; 84 ± 9% GlyT2, P = 0.09; 71 ± 9%
GlyT1 + GlyT2, P = 0.13) and necessitates increased
levels of current injection to reach spike threshold. To
further examine this we analysed the subthreshold voltage
deflections during depolarizing current injection steps
(Fig. 4). Application of strychnine (n = 12) had no
effect on subthreshold voltage responses, whereas GlyT
block reduced subthreshold voltage responses (68 ± 11%
GlyT1, P = 0.046; 76 ± 8% GlyT2, P = 0.06; 62 ± 8%
GlyT1 + GlyT2, P = 0.015 at 80 pA injection) and caused
a right-shift in current–voltage (I–V) relationships.
Synaptically evoked tonic glycine currents
To examine whether endogenously released glycine
contributed to tonic currents in PV+ INs we electrically
evoked glycinergic IPSCs using bipolar stimulation in
the presence of CNQX and bicuculline (n = 10;
2 mice). Electrical stimulation resulted in a long lasting
enhancement of the tonic current (sometimes >1 s)
seen as increased holding current and baseline noise
that was sensitive to stimulus duration (Fig. 5A). From
30 to 40 ms post-stimulation; a single eIPSC did not
significantly increase holding current (191 ± 67 pA vs.
208 ± 72 pA, P = 0.059), baseline noise (9.59 ± 3.21 pA
vs. 10.32 ± 2.38 pA, P = 0.628), and returned to baseline
in 0.69 ± 0.14 s; 10 eIPSCs at 10 Hz increased holding
current (141 ± 22 pA vs. 153 ± 23 pA, P = 0.021), but
not baseline noise (6.14 ± 1.29 pA vs. 6.32 ± 1.21 pA,
P = 0.291), and returned to baseline in 0.85 ± 0.19 s; 10
eIPSCs at 20Hz increased holding current (224± 86pA vs.
281 ± 114 pA, P = 0.032), baseline noise (8.26 ± 2.01 pA
vs. 12.12 ± 3.68 pA, P = 0.009), and returned to baseline
in 1.14 ± 0.25 s; 20 eIPSCs at 20 Hz increased holding
current (174 ± 37 pA vs. 255 ± 79 pA, P = 0.011), base-
line noise (7.29± 1.71 pA vs. 16.65± 5.91 pA, P= 0.005),
and returned to baseline in 1.23 ± 0.23 s. Bath addition
of picrotoxin (Fig. 5B; n = 3; 1 mouse) did not affect the
stimulus-evoked changes to holding current (97 ± 30 pA
vs. 91± 28 pA, P= 0.713), baseline noise (11.72± 3.12 pA
vs. 12.52 ± 4.06 pA, P = 0.619), or time to baseline
(0.96 ± 0.28 s vs. 0.90 ± 0.25 s, P = 0.433). In contrast,
these effectswere completely abolishedbybath application
of strychnine (n= 6; 2 mice) holding current (97± 30 pA
vs. 4 ± 2 pA, P < 0.001), baseline noise (11.23 ± 3.03 pA
vs. 2.82 ± 0.17 pA, P = 0.001), and reduced time to base-
line (1.05 ± 0.30 s vs. 0.11 ± 0.05 s, P < 0.001). Thus,
synaptic glycine coming from eIPSCs enhanced the tonic
glycinergic current.
To assess the functional consequences of synaptically
enhanced tonic glycine currents on PV+ IN AP discharge,
we examined excitability with (test) and without (pre-test
and post-test) a preconditioning eIPSC input (Fig. 6;
n = 13; 4 mice). In these experiments, AP discharge
was altered by the preconditioning eIPSCs in 13/34
neurons, supporting a tonic glycine current effect.
Comparisons between depolarizing step current without
(pre-test) and with (test) preceding eIPSCs (Fig. 6B)
showed eIPSCs increased rheobase current (55 ± 10 pA
for pre-test vs. 71 ± 11 pA for test, P = 0.035
vs. 55 ± 9 pA for post-test, P = 0.035), with an
associated increase in AP threshold (−34.15 ± 1.83 pA
for pre-test vs. −31.79 ± 1.97 pA for test, P = 0.002
vs. −33.46 ± 1.89 pA for post-test, P = 0.032, not
shown).Wealso assessed changes toAPnumber, frequency
and latency at rheobase + 20 pA (pre-test). Group
comparisons show that preceding eIPSCs reduced action
potential number by 38 ± 18% (10.3 ± 1.9, pre-test
vs. 6.6 ± 1.8, test, P = 0.003 vs. 8.9 ± 1.4, post-test,
P= 0.005) and increased latency to first AP by 193± 33%
(24.3 ± 3.2 ms, pre-test vs. 50.2 ± 12.4 ms, test, P= 0.018
vs. 25.6 ± 3.4 ms, post-test, P = 0.043). In contrast,
preceding eIPSCs did not change mean AP frequency
(34.6 ± 1.3 Hz, pre-test vs. 30.6 ± 2.6 Hz, test, P = 0.075
vs. 32.9 ± 1.5 Hz, post-test, P = 0.222, not shown).
Importantly, strychnine (n = 4; 1 mouse) abolished the
preconditioning eIPSC effect; rheobase (55 ± 9.6 pA,
pre-test vs. 60 ± 11.5 pA, test, P = 0.391 vs. 65 ± 15 pA,
post-test, P = 0.391); spike threshold (−32.08 ± 3.52 pA,
pre-test vs. −31.38 ± 3.24 pA, test, P = 0.095 vs.
−31.97 ± 3.51 pA, post-test, P = 0.321); action potential
number (19.3± 7.7, pre-test vs. 14.3± 5.4, test, P= 0.906
vs. 12 ± 6.1, post-test, P = 0.310); mean frequency
(40 ± 4.3 Hz, pre-test vs. 37.3 ± 4 Hz, test, P = 0.077 vs.
31.3 ± 4.7 Hz, post-test, P = 0.192); latency to first spike
(21.6 ± 5.5 ms, pre-test; 21.5 ± 5.9 ms, test, P = 0.742
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Figure 5. Evoked (endogenous) glycine release enhances tonic
glycine currents
A, top current traces show the recovery phase recorded following a
series of glycinergic eIPSCs evoked by stimulation (bipolar electrode)
of glycinergic afferents at the lamina II/III boundary, in the presence
of CNQX and bicuculline. Four stimulus protocols were employed to
produce increasing glycine release: 1 stimulus (black trace), 10
stimuli at 10 Hz (grey trace), 10 stimuli at 20 Hz (pink trace), 20
stimuli at 20 Hz (red trace). Data were obtained from a 10 ms epoch
30–40 ms after the stimulus artifact (shaded area). Note that
increasing levels of stimulation cause an increase in the amplitude
and duration of the evoked current. Bar graphs (bottom) show
changes in three current properties (baseline current and current SD)
as stimulus intensity is increased. B, top current traces show the
vs. 25.7 ± 6.7 ms, post-test, P = 0.068). Thus, end-
ogenously released glycine is capable of modulating PV+
IN excitability.
Subunit composition of tonic and synaptic
glycine receptors
It is well established that differences in GABAA receptor
subunit composition determine whether receptors are
localized to synaptic or extrasynaptic sites, and therefore
contribute to phasic or tonic inhibition (Brickley &Mody,
2012). The same information is not available for glycine
receptors. Given PV+ INs are under strong synaptic
and tonic glycinergic inhibition, they represent an ideal
model to test the relationship between glycine receptor
composition and synaptic/extrasynaptic localization. For
glycine receptors, it is well established that incorporation
of the β subunit in heteromeric glycine receptors is
critical for synaptic stabilization via the β subunit’s inter-
actions with the cytoskeletal binding protein gephyrin
(Geiman et al. 2002). Conversely, homomeric glycine
receptors, composed of five α subunits, do not interact
with gephyrin and are therefore more likely to be localized
extrasynaptically.
We set out to test if the glycine receptors mediating
tonic currents in PV+ INs had heteromeric α/β, or
homomeric α only subunit composition. Importantly,
heteromeric and homomeric glycine receptors can be
differentiated by their mean single channel conductance
(heteromeric < homomeric). Non-stationary fluctuation
analysis of tonic glycinergic currents during bath-applied
strychnine (Fig. 7A) estimated a relatively lowmean single
channel conductance of 28.8 ± 0.9 pS (n = 19), which is
consistentwithheteromeric glycine receptors. This finding
was reinforced by the observation that picrotoxin and
lindane, which show selectivity for homomeric glycine
receptors, had no effect on tonic glycinergic current
amplitude (picrotoxin: −73.5 ± 14.1 vs. 81.8 ± 14.0 pA,
n = 16, P = 0.1; lindane: −62.9 ± 7.7 vs. −64.5 ± 8.2 pA,
n = 5, P = 0.4) or noise level (picrotoxin: 7.2 ± 1.1 vs.
7.7 ± 1.0 pA, n = 16, P = 0.101; lindane: 6.1 ± 1.4 vs.
6.3±1.3pA,n=5,P=0.2) (Fig. 7B andC). Thesefindings
suggest that the tonic glycinergic currents observed in
PV+ INs are not mediated by high-conductance homo-
meric glycine receptors. Rather, they are composed of
heteromeric glycine receptors.
recovery phase after glycinergic eIPSCs (20 stimuli at 20 Hz) under
control conditions (black trace), after addition of picrotoxin (grey
trace), and after addition of strychnine (red trace). Note, picrotoxin
did not affect the response whereas strychnine abolished response
to electrical stimulation. Bar graphs (below) show group data
confirming picrotoxin (grey) has no effect on the eIPSC-related tonic
current, whereas addition of strychnine (pink) abolishes the
response. [Colour figure can be viewed at wileyonlinelibrary.com]
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
7196 M. A. Gradwell and others J Physiol 595.23
In order to confirm the synaptic glycine receptors were
also heteromeric, we under took additional experiments
to determine the mean single channel conductance
of synaptically located glycine receptors and test the
picrotoxin sensitivity of glycinergic mIPSCs. Peak scaled
non-stationary noise analysis on the decay phase of
glycinergic mIPSCs estimated a relatively low mean single
channel conductance of 28.84 ± 0.78 pS (n = 19).
This supports heteromeric α/β subunit composition at
synapses (Fig. 8A). Likewise, picrotoxin had no effect on
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Figure 6. Evoked (endogenous) glycine release alters AP
discharge in PV+ INs
A, top trace shows AP discharge responses to three depolarizing step
injections: (a) pre-test; step; (b) test step – preceded by a barrage of
eIPSCs (20 stimuli at 20 Hz via bipolar electrode); and (c) post-test
step. Traces below show current step injection and electrical
stimulation timing (red). Insets show the onset of AP discharge on
expanded time scale highlighting the delay to AP discharge and
reduced AP number in the test response (b). Right traces shows
expanded responses to the same protocol repeated in the presence
of strychnine (1 μM), which blocks glycinergic eIPSCs and associated
tonic current. Strychnine abolishes the delayed and reduced AP
discharge in test step. B, bar graphs show group data comparing
rheobase current, AP number and AP latency between the pre-test,
test and post-test step responses, confirming that eIPSCs and the
resulting tonic current reduced the excitability by modifying AP
discharge properties in PV+ INs. [Colour figure can be viewed at
wileyonlinelibrary.com]
mIPSC frequency (0.60 ± 0.1 vs. 0.54 ± 0.1 Hz, n = 8,
P = 0.39), amplitude (−54.2 ± 8.3 vs. −51.6 ± 7.0 pA,
n = 8, P = 0.51), rise time (1.2 ± 0.1 vs. 1.2 ± 0.1 ms,
n = 8, P = 0.89), or decay time constant (11.7 ± 0.8
vs. 11.2 ± 0.7 ms, n = 8, P = 0.22) (Fig. 8B and C).
Thus, we conclude that synaptic glycine receptors in
PV+ INs are also composed of α/β subunit-containing
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Figure 7. Heteromeric glycine receptors mediate tonic glycine
currents in PV+ INs
A, traces (1 s epochs) extracted from progressive block of a tonic
glycine current via strychnine application (1 μM). Non-stationary
noise analysis on the current/variance relationship during the
progressive strychnine block (right) was used to estimate the mean
single channel conductance of underlying receptors. B, trace shows
a continuous recording of mIPSCs (in the presence of TTX, CNQX
and bicuculline), during sequential bath addition of picrotoxin and
strychnine (1 μM). Note, picrotoxin does not affect the holding
current or baseline noise in PV+ INs. In contrast, strychnine causes a
shift in holding current and reduces baseline noise, thus confirming
the presence of a tonic glycine current. Right insets (a, b and c) show
no change in baseline noise after the addition of picrotoxin (b) and
its reduction by strychnine (c). An all-points histogram (right) from
epochs a, b and c shows that holding current and baseline noise do
not differ during picrotoxin exposure, but are reduced following
addition of strychnine. C, bar plots showing group data compare
holding current amplitude and baseline noise (current SD) under
control conditions (a), following bath application of picrotoxin or
lindane (b), and finally following strychnine application (c). Picrotoxin
and lindane did not alter tonic current properties suggesting these
currents are mediated by heteromeric GlyRs in PV+ INs.
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heteromers. Finally, the single channel conductance of
glycine receptors was directly assessed in outside-out
membrane patches from PV+ INs during bath-applied
glycine (2.5–10μM) (Fig. 9).Under these conditions single
channel events evoked by glycine application had a mean
conductance of 42.83 ± 1.38 pS (n= 16), were picrotoxin
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Figure 8. Heteromeric glycine receptors mediate synaptic
glycine currents in PV+ INs
A, glycinergic mIPSCs captured from PV+ INs (overlaid traces) were
used to undertake peak-scaled non-stationary noise analysis and
subsequently estimate mean single channel conductance of
synaptically located glycine receptors (right plot). PV+ INs exhibited
relatively low conductances, which is consistent with the presence of
heteromeric α/β glycine receptors. B, continuous glycinergic mIPSC
recordings prior to (control) and during picrotoxin application (left)
and overlaid mIPSCs captured under each condition. Inset (bottom
right) compares averaged mIPSCs recorded in control and picrotoxin
(traces offset for comparison). C, bar plots compare group data for
mIPSC frequency, amplitude, rise time and decay time constant
under control conditions (C) and in picrotoxin (P). Values for
individual neurons are shown as filled circles. Picrotoxin did not alter
mean mIPSC properties, thus confirming these currents are mediated
by heteromeric α/β GlyRs in PV+ INs.
insensitive (42.83± 1.38 pS vs. 47.94± 1.15 pS, n= 6) and
blocked by strychnine (n = 6). These data are consistent
with the main conductance state of previously recorded
single channel currents within the spinal cord (Bormann
et al. 1987; Takahashi et al. 1992) and provide direct
evidence of heteromeric glycine receptor composition in
PV+ INs (Lynch, 2009).
Discussion
This study has targeted PV+ INs in the mouse DH
and shows that multiple forms of glycinergic inhibition
regulate the activity of this important population. We
show that synaptic inhibition of PV+ INs is dominated
by glycinergic sources, and that tonic glycinergic currents
are also strongly expressed in this population. Given this
configuration, we assessed the stoichiometry of glycine
receptors underlying synaptic and tonic currents and show
that, surprisingly, heteromeric α/β subunit-containing
receptors dominate in both locations. Functionally, our
data emphasize the importance of glycinergic inhibition
for shaping AP discharge in PV+ INs, because enhancing
or diminishing this inhibition can decrease or increase
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Figure 9. Heteromeric glycine receptors mediate glycinergic
currents in PV+ INs
A–C, plots showing all-points histograms generated from single
channel recordings in outside-out membrane patches from PV+ INs
during bath application of glycine. Insets are example traces from
the same patch, dotted line is 2 pA. A, plot shows single channel
events after addition of glycine. B, plot shows that addition of
picrotoxin (10 μM) has no effect on channel conductance. C, plot
shows addition of strychnine abolishes single channel events. D, bar
plots showing single channel conductance from all recorded patches
(left bar) and the effect of picrotoxin on single channel conductance
(right, control (C) vs. picrotoxin (P)) in a subset of recordings. The
relatively low mean single channel conductance and picrotoxin
resistance obtained from this analysis supports the presence of
heteromeric α/β GlyRs in the patches.
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PV+ IN excitability, respectively. Given the importance
of this population in setting mechanical thresholds
and allodynia (Petitjean et al. 2015) these new data
provide insights on strategies for selectively targeting the
PV+ IN population pharmacologically through glycine
receptors.
Inhibition in the DH has long been of interest as it
is well accepted that enhanced inhibition in this region
can reduce nociceptive signalling and produce analgesia
(Zeilhofer et al. 2012). Throughout the spinal cord both
GABA and glycine mediate fast synaptic inhibition and
an extensive literature describes DH neurons under
GABAergic, glycinergic, or mixed (GABAergic and
glycinergic) inhibitory control. In general, GABAergic
inhibition is more prominent in superficial laminae,
while glycinergic inhibition dominates in deeper laminae
(Cronin et al. 2004; Anderson et al. 2009; Zeilhofer et al.
2012). This mirrors the distribution of glycinergic and
GABAergic interneurons within the DH, with GABAergic
populations being widespread in superficial laminae and
glycinergic neurons concentrated in the deep DH (Todd,
2010; Polgar et al. 2013). On a more detailed level, some
work has reported that glycinergic inhibition dominates
in lamina I of the rat, with GABAergic inhibition being
more prominent in lamina II (Chery & de Koninck, 1999).
Our work in the mouse, albeit not directly distinguishing
lamina I and lamina II, has not identified a preferential
role for glycinergic input to the most superficial regions,
nor exclusively GABAergic input in substantia gelatinosa
(Graham et al. 2003, 2011). The PV+ INs studied in the
current experiments are located in laminae IIi and III
and therefore lie at the border of superficial and deep
DH (Hughes et al. 2012). Thus, the plexus of PV+ INs in
this region may represent a more widespread transition
to glycinergic dominance within the DH. Future studies
assessing inhibition to PV-negative DH neurons in the
same region will be required to test this demarcation.
Regardless, the strong glycinergic input to PV+ INs has
functional implications, as the temporal properties of
glycinergic and GABAergic currents in this region differ.
Synaptic currents mediated by glycine have fast kinetics
with a particularly rapid decay time course (Lynch, 2004).
This feature, at least in the ventral horn, is thought to suit
strong and precisely timed inhibition in neural circuits
associated with locomotor pattern generation (Callister &
Graham, 2010; Fink et al. 2014). Previous work from our
group and others has identified a number of postsynaptic
targets for the PV-expressing population: (i) axo-axonic
synapses onto the central terminals ofmyelinated afferents
that relay innocuous tactile input to the DH (Hughes et al.
2012); (ii) axo-dendritic synapses to mediate the post-
synaptic inhibition of other PV-immunoreactive inter-
neurons (Hughes et al. 2012); and (iii) PKCγ-expressing
excitatory interneurons, that are critical for the relay of
innocuous tactile input from the deep to superficial DH
(Petitjean et al. 2015). The relative expression pattern
of axon terminals enriched in GABA and glycine, their
respective receptor subunits, or their associated anchoring
proteins within the spinal cord also imply functional
differences between the inhibition mediated by GABA
and glycine, respectively. GABA-mediated inhibition
appears to predominate in presynaptic (axo-axonic)
inhibition, and glycinergic inhibition is more important
in postsynaptic (axo-dendritic or axo-somatic) inhibition
(Todd, 1996; Watson & Bazzaz, 2001; Geiman et al.
2002; Watson et al. 2002; Watson, 2003; Lorenzo et al.
2014), Therefore, both the axo-axonic and axo-dendritic
inhibitory inputs mediated by PV+ INs appear to have
distinct roles in gating somatosensory input to ensure
that innocuous tactile afferents do not excite nociceptive
circuits. The temporal precision of glycinergic inhibition
to control PV+ IN activity may therefore be advantageous
for this regulation.
Interest in the role of glycinergic inhibition in pain
circuits has increased since reports that receptors
containing the α3 subunit of the glycine receptor are
selectively expressed in lamina II (Harvey et al. 2004),
where PV+ INs and their axonal arbors are concentrated
(Hughes et al. 2012). These α3 subunit-containing
receptors can be phosphorylated by PKA-dependent
prostaglandin E2 signalling, which results in reduced
glycinergic inhibition and inflammatory pain. It remains
to be determined whether α3 subunit-containing
receptors are involved in glycinergic inhibition on PV+
INs; however, knockout of the α3 subunit selectively
abolishes inflammatory pain. If PV+ INs do express
substantial levels of α3-containing glycine receptors
this may contribute to the observed reduction of
inflammatory pain because α3 knockout would enhance
PV+ IN-mediated inhibition. Future studies assessing α3
glycine receptor subunit expression at an ultrastructural
or molecular level will be required to resolve the relevance
of these observations for PV+ INs.
In addition to inhibitory synaptic input, a striking
feature of our recordings was the presence of robust
tonic glycinergic currents in PV+ INs (Fig. 2A).
Among recordings there was variability in the size of
these currents, indicating variation within the PV+ IN
population. Whether this variation is due to receptor
expression and density or localized extracellular glycine
concentration remains to be determined. In contrast,
we found no evidence of tonic GABA currents in PV+
INs. Tonic GABAergic currents are well described in
many regions of the CNS and are thought to reflect the
stochastic activation of GABAA receptors by basal levels of
extracellular GABA (Farrant & Nusser, 2005). Consensus
in the field indicates that these tonic currents are pre-
dominantly mediated by high affinity GABAA receptors
containing δ or α5 subunits (Brickley & Mody, 2012).
This literature underpins the view that GABAA receptors
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are selectively trafficked to either synaptic or extrasynaptic
locations based on their subunit composition.GABAergic,
as well as glycinergic, tonic currents have also been
described within the spinal dorsal horn (Takahashi
et al. 2006; Takazawa & MacDermott, 2010). For tonic
GABAergic currents, it has been confirmed that both δ
and α5 subunit-containing receptors are crucial (Bonin
et al. 2011; Bravo-Herna´ndez et al. 2016; Perez-Sanchez
et al. 2017), tonic rather than synaptic inhibition is
responsible for the major effect of neurosteroids on
GABAA receptors (Mitchell et al. 2007), and that each
receptor type is functionally relevant for nociceptive
processing. This work suggests tonic GABAergic currents
play roles in normal resolution of hyperalgesia following
acute inflammation (Perez-Sanchez et al. 2017), as well
as limiting acute nociception and central sensitization
(Bonin et al. 2011). In contrast, some work suggests that
tonic GABAergic currents can contribute to more chronic
forms of pain following inflammation and nerve injury
(Bravo-Herna´ndez et al. 2016). Less work has assessed the
properties and roles of tonic glycinergic currents in the
dorsal horn and thus the potential for different receptor
stoichiometry between extrasynaptic versus synaptic GlyR
pools has remained unresolved. Despite this, it is widely
accepted that synaptic stabilizationofGlyRs requires inter-
actions between the β-subunit and the scaffolding protein
gephyrin, implying synaptic inhibition is mediated by
heteromeric α/βGlyRs (Graham et al. 2006; Lynch, 2009).
By extension, it has been assumed that homomeric GlyRα
receptors preferentially contribute to tonic inhibition. In
contrast our data indicate that, at least in the PV+ IN
population, heteromeric α/βGlyRsmediate both synaptic
and tonic inhibition. Therefore, the relative expression
of GlyRs at synaptic versus extrasynaptic sites appears to
be a function of synaptic stabilization sites (i.e. gephyrin
expression) and the overall expression of heteromeric α/β
GlyRs. Thus, regulation of the subcellular distribution of
GlyRs differs from GABAARs and is not dictated by sub-
unit stoichiometry. Future work in other DH populations
will be required to determine if this is a fundamental
difference between receptor types, or specific to the PV+
IN population.
Another study in the glutamate decarboxylase 67
(GAD67)-GFP mouse established more broadly that
inhibitory interneurons in the DH can express either
GABAergic or glycinergic tonic currents (Takazawa &
MacDermott, 2010). This work showed that inhibitory
neurons at the lamina II/III border were more likely
to express tonic glycinergic than GABAergic currents,
and that the glial glycine transporter (GlyT1) played
a role in regulating tonic glycinergic currents. The
similarity of these observations to our own raises the
possibility that PV+ INs may have been included in
the GAD67-GFP dataset. Our experiments have extended
these findings showing that both GlyT1 and the neuronal
glycine transporter (GlyT2) have powerful effects on
tonic glycinergic currents in PV+ INs. The role of each
transporter appears similar, as we found the change
in tonic current amplitude and baseline noise to be
similar regardless of which transporter was blocked. Our
sequential blocking experiments demonstrate a dramatic
effect on tonic currents when both transporters are
blocked (Fig. 3), greater than the simple sumof each trans-
porter’s effect. Furthermore, this effect was not altered by
the order of blockade (i.e. GlyT1 block followed by GlyT2
block, or GlyT2 block followed by GlyT1 block). These
findings imply that when a single transporter is blocked,
the alternative transporter can partially compensate,
irrespective of order. Once both transporters are blocked,
however, a rapid rise in extracellular glycine concentration
can powerfully augment the tonic glycinergic current.
Regarding the functional relevance of tonic glycine
currents, tonic GABA currents in the cerebellum,
hippocampus, olfactory bulb and cortex have been
shown to regulate neuronal excitability by modulating
neuronal input resistance and membrane time constant
to alter action potential threshold, discharge pattern
and input/output gain (Semyanov et al. 2004; Brickley
& Mody, 2012). Studies on tonic currents in DH
neurons recorded from GAD67-GFP mice have also
shown that blocking both GABA and glycine receptors
alters neuronal excitability to enhance action potential
discharge (Takazawa & MacDermott, 2010). However,
these recordings were made from a heterogeneous
population of inhibitory interneurons and did not
differentiate between the effect of tonic GABA and glycine
currents. Our targeted experiments in PV+ INs show that
glycine receptor block enhances neuronal excitability in
this population. This was most striking when the initial
bursting discharge mode was converted to tonic firing
after glycine receptor block. It is unclear from our data
whether this effect was mediated by block of synaptic or
tonic currents, as there is no way to selectively block each
form of inhibition. The sustained versus phasic nature of
tonic and synaptic inhibition, argues that tonic glycine
currents play a critical role in this phenomenon (Farrant
& Nusser, 2005).
Experiments that enhanced glycinergic inhibition by
blocking glycine transporter activity reduced PV+ IN
excitability. This is predictable as increasing tonic glycine
currents should lower neuronal input resistance, as has
been shown for tonic GABA currents, and increase the
level of depolarization required to reach action potential
threshold. Inmany instances (17/21) transporter blockade
converted tonic firing into initial bursting, and when
both transporters were blocked AP discharge was almost
completely abolished. These findings are particularly
relevant in light of the recent interest in glycine transporter
blockers as potential analgesics (Vandenberg et al. 2014). A
number of preclinical studies have confirmed that intra-
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venous or intrathecal administration of either GlyT1 or
GlyT2 blockers provides analgesia in models of acute and
neuropathic pain (Morita et al. 2008; Tanabe et al. 2008;
Haranishi et al. 2010; Nishikawa et al. 2010). The GlyT2
blockers are considered more promising targets because
their expression is limited to inhibitory interneurons
and their effects are confined to inhibitory synapses.
In contrast, GlyT1 expression is largely glial and affects
inhibitory (glycinergic) synapses, as well as excitatory
synapses throughNMDAreceptor activation (Vandenberg
et al. 2014). The premise behind these findings is that
glycine transporter block increases extracellular glycine
concentrations to enhance glycine receptor activation and
signalling, and thus reduce nociceptive transmission in
the DH. Certainly, patch clamp recordings from lamina
X neurons have confirmed that block of either GlyT1
or GlyT2 transporters enhances synaptic inhibition by
prolonging the decay time course of glycinergic currents
(Bradaia et al. 2004). Not withstanding these findings,
our data indicate that transporter blockade augments
tonic glycinergic currents to decrease the activity of PV+
INs, and reduce the inhibition they mediate in DH
circuits. Given the clear role PV+ INs have in segregating
tactile and nociceptive circuits such a change would allow
innocuous tactile input to excite nociceptive circuits and
cause allodynia, as has been shown when PV+ INs are
selectively ablated (Petitjean et al. 2015). This outcome,
while seemingly incompatible with the analgesia observed
in vivo,maybe counterbalancedby the concurrent increase
in synaptic inhibition arising by other populations of
inhibitory interneurons that do not express PV.
In conclusion, this study shows that both synaptic and
tonic forms of glycinergic inhibition play critical roles in
the normal function of PV+ INs in the spinalDH.As these
neurons have been shown to be important in blunting
innocuous tactile input to nociceptive circuits, the fast
synaptic inhibition provided by glycine receptors may be
critical to achieve temporally specific sensory gating in
these circuits. Furthermore, tonic glycine currents also
provide an additional mechanism for controlling PV+ IN
excitability, and consequently, the levels of inhibition they
can mediate. Importantly, we also show that heteromeric
α/β GlyRs dominate in the generation of both synaptic
and tonic currents, an important consideration for future
pharmacological targeting of glycinergic inhibition in
the DH. Together, these findings suggest that alterations
in glycinergic input in the PV+ population could
either block or produce pathological sensations such as
allodynia. Future work assessing these characteristics in
various pain models will determine whether disrupted
glycinergic inhibition of PV+ INs contributes to pain
under pathological conditions. Furthermore, the capacity
of glycine transporter blockade to diminish PV+ IN
excitability warrants caution if these approaches are to
progress as novel analgesic therapies.
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